Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy

Cancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the int...

Full description

Bibliographic Details
Main Authors: Carla Contaldi, Vincenzo Montesarchio, Dario Catapano, Luigi Falco, Francesca Caputo, Carmine D’Aniello, Daniele Masarone, Giuseppe Pacileo
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/10/2103
_version_ 1797573259074469888
author Carla Contaldi
Vincenzo Montesarchio
Dario Catapano
Luigi Falco
Francesca Caputo
Carmine D’Aniello
Daniele Masarone
Giuseppe Pacileo
author_facet Carla Contaldi
Vincenzo Montesarchio
Dario Catapano
Luigi Falco
Francesca Caputo
Carmine D’Aniello
Daniele Masarone
Giuseppe Pacileo
author_sort Carla Contaldi
collection DOAJ
description Cancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the intricate relationship between cancer therapy and the cardiovascular system, highlighting the role of advanced multimodality imaging in monitoring patients before, during, and after cancer treatment. This review outlines the cardiovascular effects of different cancer therapy classes, offering a comprehensive understanding of their dose- and time-dependent impacts. This paper delves into diverse imaging modalities such as echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, and nuclear imaging, detailing their strengths and limitations in various conditions due to cancer treatment, such as cardiac dysfunction, myocarditis, coronary artery disease, Takotsubo cardiomyopathy, pulmonary hypertension, arterial hypertension, valvular heart diseases, and heart failure with preserved ejection fraction. Moreover, it underscores the significance of long-term follow-up for cancer survivors and discusses future directions.
first_indexed 2024-03-10T21:07:18Z
format Article
id doaj.art-d20358a99f584a748e4644ebeb3c09c8
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T21:07:18Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-d20358a99f584a748e4644ebeb3c09c82023-11-19T17:07:27ZengMDPI AGLife2075-17292023-10-011310210310.3390/life13102103Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer TherapyCarla Contaldi0Vincenzo Montesarchio1Dario Catapano2Luigi Falco3Francesca Caputo4Carmine D’Aniello5Daniele Masarone6Giuseppe Pacileo7Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyDivision of Medical Oncology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyHeart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, ItalyCancer therapies have revolutionized patient survival rates, yet they come with the risk of cardiotoxicity, necessitating effective monitoring and management. The existing guidelines offer a limited empirical basis for practical approaches in various clinical scenarios. This article explores the intricate relationship between cancer therapy and the cardiovascular system, highlighting the role of advanced multimodality imaging in monitoring patients before, during, and after cancer treatment. This review outlines the cardiovascular effects of different cancer therapy classes, offering a comprehensive understanding of their dose- and time-dependent impacts. This paper delves into diverse imaging modalities such as echocardiography, cardiac magnetic resonance imaging, cardiac computed tomography, and nuclear imaging, detailing their strengths and limitations in various conditions due to cancer treatment, such as cardiac dysfunction, myocarditis, coronary artery disease, Takotsubo cardiomyopathy, pulmonary hypertension, arterial hypertension, valvular heart diseases, and heart failure with preserved ejection fraction. Moreover, it underscores the significance of long-term follow-up for cancer survivors and discusses future directions.https://www.mdpi.com/2075-1729/13/10/2103cardiotoxicityechocardiographycardiac magnetic resonancecardiac computed tomographynuclear imagingcancer therapy
spellingShingle Carla Contaldi
Vincenzo Montesarchio
Dario Catapano
Luigi Falco
Francesca Caputo
Carmine D’Aniello
Daniele Masarone
Giuseppe Pacileo
Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
Life
cardiotoxicity
echocardiography
cardiac magnetic resonance
cardiac computed tomography
nuclear imaging
cancer therapy
title Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
title_full Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
title_fullStr Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
title_full_unstemmed Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
title_short Multimodality Cardiovascular Imaging of Cardiotoxicity Due to Cancer Therapy
title_sort multimodality cardiovascular imaging of cardiotoxicity due to cancer therapy
topic cardiotoxicity
echocardiography
cardiac magnetic resonance
cardiac computed tomography
nuclear imaging
cancer therapy
url https://www.mdpi.com/2075-1729/13/10/2103
work_keys_str_mv AT carlacontaldi multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT vincenzomontesarchio multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT dariocatapano multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT luigifalco multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT francescacaputo multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT carminedaniello multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT danielemasarone multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy
AT giuseppepacileo multimodalitycardiovascularimagingofcardiotoxicityduetocancertherapy